Znaidi Sadri, De Deken Xavier, Weber Sandra, Rigby Tracey, Nantel André, Raymond Martine
Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada H3C 3J7.
Mol Microbiol. 2007 Oct;66(2):440-52. doi: 10.1111/j.1365-2958.2007.05931.x.
The Candida albicans PDR16 gene, encoding a putative phosphatidylinositol transfer protein, is co-induced with the multidrug transporter genes CDR1 and CDR2 in azole-resistant (A(R)) clinical isolates and upon fluphenazine exposure of azole-susceptible (A(S)) cells, suggesting that it is regulated by Tac1p, the transcriptional activator of CDR genes. Deleting TAC1 in an A(R) isolate (5674) overexpressing PDR16, CDR1 and CDR2 decreased the expression of the three genes and fluconazole resistance to levels similar to those detected in the matched A(S) isolate (5457), demonstrating that Tac1p is responsible for PDR16 upregulation in that strain. Deleting TAC1 in the A(S) strain SC5314 abolished CDR2 induction by fluphenazine and decreased that of PDR16 and CDR1, uncovering the participation of an additional factor in the regulation of PDR16 and CDR1 expression. Sequencing of the TAC1 alleles identified one homozygous mutation in strain 5674, an Asn to Asp substitution at position 972 in the C-terminus of Tac1p. Introduction of the Asp(972) allele in a tac1Delta/Delta mutant caused high levels of fluconazole resistance and TAC1, PDR16, CDR1 and CDR2 constitutive induction. These results demonstrate that: (i) Tac1p controls PDR16 expression; (ii) Asn(972) to Asp(972) is a gain-of-function mutation; and (iii) Tac1p is positively autoregulated, directly or indirectly.
白色念珠菌的PDR16基因编码一种假定的磷脂酰肌醇转移蛋白,在耐唑类(A(R))临床分离株中与多药转运蛋白基因CDR1和CDR2共同诱导表达,并且在唑类敏感(A(S))细胞暴露于氟奋乃静时也会如此,这表明它受CDR基因的转录激活因子Tac1p调控。在过表达PDR16、CDR1和CDR2的A(R)分离株(5674)中缺失TAC1,可使这三个基因的表达以及对氟康唑的耐药性降低至与匹配的A(S)分离株(5457)中检测到的水平相似,这表明Tac1p负责该菌株中PDR16的上调。在A(S)菌株SC5314中缺失TAC1可消除氟奋乃静对CDR2的诱导作用,并降低PDR16和CDR1的诱导作用,揭示了另一个因子参与PDR16和CDR1表达的调控。对TAC1等位基因进行测序,在菌株5674中鉴定出一个纯合突变,即Tac1p C末端第972位的天冬酰胺被天冬氨酸取代。在tac1Delta/Delta突变体中引入Asp(972)等位基因会导致高水平的氟康唑耐药性以及TAC1、PDR16、CDR1和CDR2的组成型诱导。这些结果表明:(i)Tac1p控制PDR16的表达;(ii)天冬酰胺(972)到天冬氨酸(972)是一个功能获得性突变;(iii)Tac1p直接或间接受正向自身调节。